Patents by Inventor Stanley A. Kline

Stanley A. Kline has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8097405
    Abstract: A process for determining the sequence of nucleic acids of interest employs nucleotides or nucleotide analogs that have been made detectable by non-radioactive modifying or labeling. Such nucleotides or nucleotide analogs are modified on the sugar moieties, the phosphate moieties or the base moieties, including base analogs. Modified nucleotide analogs can be attached to or coupled to or incorporated into DNA or RNA. The modified or labeled nucleotides or nucleotide analogs are also useful in processes for detecting the presence of nucleic acids of interest and for characterizing chromosomal sequences. Detection processes using the modified or labeled nucleotides or nucleotide analogs extend to the use of a gel for separating or resolving hybrids formed between non-radioactively labeled oligonucleotides or polynucleotides and such nucleic acids of interest.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 17, 2012
    Assignee: Enzo Biochem, Inc.
    Inventors: Dean Engelhardt, Elazar Rabbani, Stanley Kline, Jannis G. Stavrianopoulos, Dollie Kirtikar
  • Patent number: 7220854
    Abstract: The present invention provides a nucleotide having the formula, wherein PM is a phosphate moiety, SM is a ribose or a deoxyribose sugar moiety, and BASE is a pyrimidine, purine or 7-deazapurine moiety. PM is attached to SM at a position independently selected from the 2?, 3?, and 5? positions of SM when the nucleotide is a ribonucleotide, and at a position independently selected from the 3? and 5? positions when the nucleotide is a deoxyribonucleotide. BASE is attached to the 1? position of SM from the N1 position when BASE is a pyrimidine, or the N9 position when BASE is a purine or 7-deazapurine. Sig is a detectable moiety covalently attached to SM directly or through a linkage group. Also provided are an oligo- or polynucleotide comprising at least one such sugar moiety labeled nucleotide, and other compositions including those wherein a polypeptide is terminal ligated or attached to the oligo- or polynucleotide.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 22, 2007
    Assignee: Enzo Life Sciences, Inc. c/o Enzo Biochem, Inc.
    Inventors: Dean Engelhardt, Elazar Rabbani, Stanley Kline, Jannis G. Stavrianopoulos, Dollie Kirtikar
  • Publication number: 20060160403
    Abstract: A contact for a wire tap connector includes a substantially planar insulation displacement portion configured to receive a primary wire and electrically connect thereto, and a poke in wire section integrally formed with and attached to the planar insulation displacement portion. The poke in wire section is configured to accept a prepared connecting wire in one or more positions relative to the insulation displacement portion. When the contact is situated in a housing, a slidable stuffer may be provided to quickly and easily install the connector assembly to a primary run wire.
    Type: Application
    Filed: January 14, 2005
    Publication date: July 20, 2006
    Inventors: Scott Duesterhoeft, David Fabian, Stanley Kline
  • Patent number: 6992180
    Abstract: The present invention provides a nucleotide having the formula, Sig-PM-SM-BASE wherein PM is a phosphate moiety, SM is a sugar moiety and BASE is a pyrimidine, purine or 7-deazapurine moiety. PM is attached to the 3? or the 5? position of the sugar moiety when the nucleotide is a deoxyribonucleotide and at the 2?, 3? or 5? position when the nucleotide is a ribonucleotide. BASE is attached to the 1? position of SM from the N1 position when BASE is a pyrmidine or the N9 position when BASE is a purine or 7-deazapurine. Sig is covalently attached to PM directly or via a chemical linkage, and represents a detectable moiety covalently attached to SM directly or through a linkage group. Also provided are an oligo- or polynucleotide comprising at least one such phosphate-moiety labeled nucleotide, and other compositions including those wherein a polypeptide is terminally ligated or attached to the oligo- or polynucleotide.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 31, 2006
    Assignee: Enzo Life Sciences, Inc. c/o Enzo Biochem, Inc.
    Inventors: Dean Engelhardt, Elazar Rabbani, Stanley Kline, Janes G. Stavrianopoulos, Dollie Kirtikar
  • Patent number: 6544046
    Abstract: An electrical connector mountable to a substrate. The electrical connector comprises a housing, and a surface mount contact and hold down both secured to the housing. The hold down may be a surface mount hold down. A ball grid array connector comprising a housing, a plurality of contacts secured to the housing, a plurality of fusible elements secured to the contacts for mounting the connector to a substrate, and a hold down secured to the housing. The hold down may be a surface mount hold down. A method of mounting an electrical connector to a substrate. The method comprises providing a substrate and an electrical connector having a contact and a hold down, and securing the contact and the hold down to the substrate. The contact may be secured to a surface of the substrate. A method of securing an electrical connector to a substrate. The method comprises providing a substrate and an electrical connector having a contact and a hold down, and mounting the contact to the substrate.
    Type: Grant
    Filed: October 19, 2000
    Date of Patent: April 8, 2003
    Assignee: FCI Americas Technology, Inc.
    Inventors: Marlyn E. Hahn, Stanley A. Kline, Joseph B. Shuey
  • Patent number: 5384241
    Abstract: Disclosed is an assay system including a compound comprising an analyte-specific moiety having substituted thereon a polymer comprising plurality of self-quenching emitter moieties and a plurality of isocharged functionality separating the emitter moieties. The present invention provides compounds that overcome the undesirable effects of self-quenching when multiple emitter moieties are used for labelling of assay reagents. Avoidance of this self-quenching phenomenon by the compounds of the invention makes it possible to introduce a more concentrated degree of labelling on to analyte-specific molecules such as oligo nucleotide probes, antibodies and other specific binding proteins and analyte-specific polysaccharides. Therefor, it is possible to effect greater assay sensitivity because the number of labels per recognition molecule(analyte-specific moiety) can be increased beyond the point previously possible without the reduction in signal caused by self-quenching.
    Type: Grant
    Filed: November 29, 1989
    Date of Patent: January 24, 1995
    Assignee: Enzo Diagnostics, Inc.
    Inventor: Stanley Kline
  • Patent number: 5260433
    Abstract: The present invention provides nucleotides and polynucleotides which are chemically modified or labeled so as to be capable of ready detection when attached to and/or incorporated in nucleic acid material. More particularly, this invention provides a nucleotide selected from the group consisting of (i) a ribonucleotide having the formula, ##STR1## wherein PM is a phosphate moiety, SM is a sugar moiety, BASE is a pyrimidine, purine or 7-deazapurine moiety, and Sig is a saccharide moiety. PM is attached at the 2',3' or 5' position of SM, BASE is attached to the 1' position of SM from the N.sup.1 position when BASE is a pyrimidine or covalently attached to SM; and (ii) a nucleotide having the formula, ##STR2## wherein PM, SM, BASE and Sig are as defined above but PM is attached to the 3' or the 5' position of SM when said nucleotide is a deoxyribonucleotide and at the 2', 3' or 5' position when said nucleotide is a ribonucleotide, BASE is attached to the 1' position of SM from the N.sup.
    Type: Grant
    Filed: August 13, 1990
    Date of Patent: November 9, 1993
    Assignee: Enzo Diagnostics, Inc.
    Inventors: Dean Engelhardt, Elazar Rabbani, Stanley Kline, Jannis G. Stavrianopoulos, Dollie Kirtikar
  • Patent number: 5241060
    Abstract: The present invention provides nucleotides and polynucleotides which are chemically modified or labeled so as to be capable of ready detection when attached to and/or incorporated in nucleic acid material. More particularly, this invention provides a nucleotide having the formulaPM-SM-BASE-Sigwherein PM is a phosphate moiety, SM is a sugar moiety and BASE is a pyrimidine, purine or 7-deazapurine moiety. PM is attached at the 3' or the 5' position of SM when the nucleotide is a deoxyribonucleotide and at the 2', 3' or 5' position when the nucleotide is a ribonucleotide. BASE is attached to the 1' position of SM from the N.sup.1 position when BASE is a pyrimidine or the N.sup.9 position when BASE is a purine or a 7-deazapurine. Sig is a detectable moiety that is covalently attached to BASE at a position other than the C.sup.5 position when BASE is a pyrimidine, at a position other than the C.sup.8 position when BASE is a purine and at a position other than the C.sup.7 position when BASE is a 7-deazapurine.
    Type: Grant
    Filed: June 4, 1990
    Date of Patent: August 31, 1993
    Assignee: Enzo Diagnostics, Inc.
    Inventors: Dean Engelhardt, Elazar Rabbani, Stanley Kline, Jannis G. Stavrianopoulos, Dollie Kirtikar